What is Velcade?

Category: Prescription Drugs

true

Generic name: Bortezomib

Velcade® is the brand name for bortezomib, an oral medication used for the treatment of multiple myeloma. It may also be used to treat a variety of specific types of lymphomas.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 4
Moderate 10
Mild 10
None 10

Commonly reported side effects and conditions associated with Velcade

Side effect Patients
Fatigue 7
Chronic constipation 2
Constipation 2
Dizziness 2
Peripheral neuropathy 2
Tiredness 2

Show all 27 reported side effects

Dosages

Based on patients currently taking Velcade

Dosage Patients
3.5 mg weekly 3
3.5 mg monthly 1

Why patients stopped taking Velcade

Multiple reasons could be selected

Reason Patients
Doctor's advice 8
Course of treatment ended 7
Side effects too severe 6
Other 3
Did not seem to work 2
See all 22 patients who've stopped taking Velcade

Duration

Currently taking Velcade

Duration Patients
6 months - 1 year 1
1 - 2 years 1
2 - 5 years 1
5 - 10 years 2
10 years or more 1

Stopped taking Velcade

Duration Patients
Less than 1 month 4
1 - 6 months 7
6 months - 1 year 5
1 - 2 years 2
2 - 5 years 4
Adherence
Adherence Evaluations
Always 33
Usually 0
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 4
A little hard to take 8
Not at all hard to take 22
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 3
$25-49 0
< $25 10
Not specified 21

What people switch to and from

Patients started taking Velcade after stopping:

Treatment Patients
Lenalidomide (Revlimid) 5
Lenalidomide-dexamethasone (Rd) 2

Patients stopped taking Velcade and switched to:

Treatment Patients
Carfilzomib (Kyprolis) 3
Lenalidomide (Revlimid) 3
Daratumumab (Darzalex) 2
Dexamethasone (Decadron) 1
Elotuzumab (Empliciti) 1

Show all 6 treatments patients report switching to

Last updated:
There are no evaluations for Velcade.